Siemens Healthineers, a German medical technology firm, has cut its 2026 revenue growth forecast to a range of 3.5% to 4.0% due to China’s procurement policy weighing on its diagnostics business.
The company’s third-quarter revenue rose 1.8% to €5.76 billion, missing the LSEG consensus estimate by 0.8%. The adjusted operating profit margin increased to 19.1% from 16.8% year-over-year.
Siemens Healthineers also raised its outlook for adjusted earnings per share to between €2.35 and €2.45, reflecting the amount of U.S. tariff refunds.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.